CoreWeave, Inc.
CRWV Nasdaq Services-Prepackaged Software Financials FY2023βFY2025
What CoreWeave, Inc. does
No business description yet.
- Legal name
- CoreWeave, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0001769628-26-000104
0001769628
Revenue and margins
CoreWeave, Inc. had $5.1B of revenue in fiscal 2025, up 167.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$7.3B in fiscal 2025, β141.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CoreWeave, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 100.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably CoreWeave, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $217M | $1.4B | $3.2B |
| Debt incl. finance leases | β | $8.0B | $21.6B |
| Net debt / EBITDA | β | 5.6x | 7.7x |
| Debt / equity | β | β | 6.4x |
| Interest coverage | β0.5x | 0.9x | β0.0x |
| Current ratio | β | 0.4x | 0.5x |
| Quick ratio | β | 0.4x | 0.5x |
| Total assets | β | $17.8B | $49.3B |
| Total liabilities | β | $16.5B | $46.0B |
| Shareholders' equity | β$597M | β$414M | $3.3B |
| Net debt (β = net cash) | β | $6.7B | $18.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 9 |
| Accruals ratio | β | β20.3% | β12.6% |
| Altman Z'' | β | β1.29 | β1.30 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $229M | $1.9B | $5.1B |
| Gross profit | $160M | $1.4B | $3.7B |
| Research and development | $21.0M | $56.0M | $352M |
| Operating income | β$14.0M | $324M | β$46.0M |
| Interest expense | $27.0M | $349M | $1.1B |
| Pretax income | β$558M | β$744M | β$1.2B |
| Income tax | $36.0M | $119M | β$48.0M |
| Net income | β$594M | β$863M | β$1.2B |
| Net income to common | β$594M | β$937M | β$1.2B |
| Diluted EPS | β$3.09 | β$4.30 | β$2.81 |
| Diluted shares | 0.19B | 0.22B | 0.44B |
| Cash flow | |||
| Cash from operations | $1.8B | $2.7B | $3.1B |
| Capital expenditure | $2.9B | $8.7B | $10.3B |
| Free cash flow | β$1.1B | β$6.0B | β$7.3B |
| Depreciation and amortization | $103M | $863M | $2.5B |
| Stock-based compensation | $15.0M | $31.0M | $630M |
| Acquisitions | $0.0M | $0.0M | $108M |
| Balance sheet | |||
| Cash and short-term investments | $217M | $1.4B | $3.2B |
| Total debt | β | $7.9B | $21.4B |
| Finance lease liabilities | β | $92.0M | $254M |
| Current assets | β | $1.9B | $7.5B |
| Current liabilities | β | $5.0B | $16.4B |
| Property and equipment, net | β | $11.9B | $30.6B |
| Goodwill | $0.0M | $20.0M | $1.1B |
| Intangible assets | β | $5.0M | $235M |
| Total assets | β | $17.8B | $49.3B |
| Total liabilities | β | $16.5B | $46.0B |
| Preferred stock | β | $0.0M | $0.0M |
| Shareholders' equity | β$597M | β$414M | $3.3B |
| Margins | |||
| Gross margin | 69.9% | 74.3% | 71.7% |
| Operating margin | β6.1% | 16.9% | β0.9% |
| EBITDA margin | 38.9% | 62.0% | 46.9% |
| Net margin | β259.4% | β45.1% | β22.7% |
| FCF margin | β484.7% | β310.9% | β141.3% |
| Returns | |||
| Return on capital | β | 4.2% | β0.2% |
| Return on capital employed | β | 2.5% | β0.1% |
| Return on equity | β | β | β79.9% |
| Return on assets | β | β4.8% | β3.5% |
| Return on tangible equity | β | β | β59.8% |
| Growth | |||
| Revenue growth | β | 736.2% | 167.9% |
| Share count change | β | 13.5% | 100.0% |
| Financial health | |||
| Net debt / EBITDA | β | 5.6x | 7.7x |
| Debt / equity | β | β | 6.4x |
| Interest coverage | β0.5x | 0.9x | β0.0x |
| Current ratio | β | 0.4x | 0.5x |
| Quick ratio | β | 0.4x | 0.5x |
| Capital allocation | |||
| Capex / revenue | 1,285.2% | 454.4% | 200.9% |
| Stock comp / revenue | 6.6% | 1.6% | 12.3% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | β1.3 | β1.3 |
| Accruals ratio | β | β20.3% | β12.6% |
Source: SEC EDGAR XBRL filings (CIK 0001769628). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.